About us

A Szentágothai János Kutatóközpont a PTE korszerű, nemzetközi tudományszervezési és menedzsment normák szerint kialakított új intézménye, amely az élettudományi, élettelen természettudományi, valamint környezettudományi oktatás...



This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.


National Laboratory of Translational Neuroscience

  • Sajtóközlemény / Press release

New national laboratory to improve methodology for the treatment of neurological diseases

In 2022, the University of Pécs, as the consortium leader, and its six consortium partners (HUN-REN Research Institute of Experimental Medicine, University of Szeged, Semmelweis University, HUN-REN Natural Sciences Research Centre, HUN-REN Computer and Automation Research Institute, Richter Gedeon public Ltd.) won HUF 5.300 billion in non-reimbursable EU funding under the RRF-2. 3.1-21 "Establishment and complex development of national laboratories". The project "Translational Neuroscience National Laboratory" (TINL), RRF-2.3.1-21-2022-00011, is implemented under the Széchenyi Plan Plus programme and focuses on two main thematic areas: neurodevelopmental disorders (NDD) and adult neurodevelopmental disorders.

The TINL aims to improve the prevention and treatment of neurological diseases with a unique research spectrum covering neurological disorders and diseases from childhood to adulthood. The mission of the TINL programme is to develop a comprehensive understanding of the disease mechanisms underlying neurological disorders in early life and, thereby, to develop new diagnostic and intervention options. Neurodevelopmental disorders result from a complex interplay of genetic and environmental factors. While the enormous social and economic impact of neurodevelopmental diseases is increasingly recognised in developed societies, neurological disorders in early life represent a lifelong burden for patients, their relatives and society as a whole. It is clear that from the emergence of the first neurons in the embryo to the development of the mature nervous system, the developing brain can be subject to a wide range of pathological effects that can lead to neurological diseases and mental disorders. Neurodevelopmental disorders include, for example, fetal alcohol syndrome, neonatal hypoxic brain injury, autism and attention deficit hyperactivity disorder in childhood.

The Adult Neurological Disorders programme aims to 'save the salvageable', developing new treatments that offer treatment alternatives for this 'unrecognised epidemic', reducing the most significant burden on the health economy. As digital medicine and data-driven healthcare are gaining ground, the aim is to directly exploit real-life data in the therapy of neurological pathologies by developing online platforms/registries capable of uploading online data following the structure of existing neuroscience databases, preserving the searchability of existing databases and integrating health data generated by other institutions, clinical and National Health Insurance Fund (NEAK) and Governmental Agencies (e.g. prescription, hospital costs, patient journeys, outcomes, etc.); it is also compatible with other clinical research programmes and databases; it takes into account health insurance and health management needs; and health industry needs for utilisation such as quality assurance, audit, drug and procedure trials, good practice identification, cross-validation.

The project will be implemented at the research sites of the consortium members and their networks.

More information is available on request:

Gergely Kottász, Press Officer kottasz.gergely@pte.hu, +36/309661257 For more information about the project, please visit https://nkfih.gov.hu/transzlacios-idegtudomanyi-nemzeti-laboratorium/laboratorium-bemutatasa

Prof. Dr. Tamás Dóczi
Research Group Leader
 72/535-900/37708 377695